JP2008074747A - Collagen production promoter - Google Patents
Collagen production promoter Download PDFInfo
- Publication number
- JP2008074747A JP2008074747A JP2006254393A JP2006254393A JP2008074747A JP 2008074747 A JP2008074747 A JP 2008074747A JP 2006254393 A JP2006254393 A JP 2006254393A JP 2006254393 A JP2006254393 A JP 2006254393A JP 2008074747 A JP2008074747 A JP 2008074747A
- Authority
- JP
- Japan
- Prior art keywords
- chemical formula
- collagen production
- production promoter
- collagen
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000037319 collagen production Effects 0.000 title claims abstract description 30
- 229920001461 hydrolysable tannin Polymers 0.000 claims abstract description 29
- JCGHAEBIBSEQAD-UUUCSUBKSA-N eugeniin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@@H]3OC(=O)C4=CC(O)=C(O)C(O)=C4C4=C(O)C(O)=C(O)C=C4C(=O)OC[C@H]3O2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 JCGHAEBIBSEQAD-UUUCSUBKSA-N 0.000 claims abstract description 24
- 102000001187 Collagen Type III Human genes 0.000 claims abstract description 15
- 108010069502 Collagen Type III Proteins 0.000 claims abstract description 15
- 229920001990 Tellimagrandin II Polymers 0.000 claims abstract description 13
- JCGHAEBIBSEQAD-ANGOHYEVSA-N Tellimagrandin II Natural products O=C(O[C@@H]1[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)O[C@@H]2[C@@H]([C@@H]1OC(=O)c1cc(O)c(O)c(O)c1)OC(=O)c1c(c(O)c(O)c(O)c1)-c1c(O)c(O)c(O)cc1C(=O)OC2)c1cc(O)c(O)c(O)c1 JCGHAEBIBSEQAD-ANGOHYEVSA-N 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims description 56
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 abstract description 14
- 239000000284 extract Substances 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 9
- 102000008186 Collagen Human genes 0.000 abstract description 8
- 108010035532 Collagen Proteins 0.000 abstract description 8
- 229920001436 collagen Polymers 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 4
- 210000004207 dermis Anatomy 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 241000532931 Duabanga grandiflora Species 0.000 abstract description 2
- 235000005538 Duabanga sonneratioides Nutrition 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 238000000605 extraction Methods 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 241000532930 Duabanga Species 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 239000012046 mixed solvent Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- XFYIHRTWDXNCTA-UHFFFAOYSA-N Eugenin Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC1CCC2C(C)(CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1C XFYIHRTWDXNCTA-UHFFFAOYSA-N 0.000 description 7
- 239000003463 adsorbent Substances 0.000 description 7
- SUTUBQHKZRNZRA-UHFFFAOYSA-N eugenin Chemical compound O1C(C)=CC(=O)C=2C1=CC(OC)=CC=2O SUTUBQHKZRNZRA-UHFFFAOYSA-N 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000003021 water soluble solvent Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 3
- 108010022452 Collagen Type I Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 3
- 244000223014 Syzygium aromaticum Species 0.000 description 3
- -1 and the like Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 0 Cc(c(C(*)=O)cc(O)c1O)c1O Chemical compound Cc(c(C(*)=O)cc(O)c1O)c1O 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241001470257 Nagara Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- OHDRQQURAXLVGJ-AXMZSLBLSA-N azane;(2z)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-AXMZSLBLSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000003918 fraction a Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、コラーゲン産生促進剤、特にIII型コラーゲン産生促進剤に関する。 The present invention relates to a collagen production promoter, particularly a type III collagen production promoter.
加齢や紫外線等外来ストレスにより生じるしわ、シミの発生、皮膚弾性の低下といった皮膚の老化症状には、皮膚真皮の線維芽細胞の機能低下、コラーゲンの変性や減少、ヒアルロン酸をはじめとするムコ多糖類の減少、紫外線によるメラニンの形成と沈着、細胞の酸化が重要な要因となっている。しかし、従来の化粧品のように、ムコ多糖類やコラーゲンなどの生化学製品および合成高分子製品を配合して水分保持に努めるだけでは、皮膚の老化症状を十分に防止することができないことも明らかとなっている。そこで、皮膚の老化防止、改善作用を有する皮膚外用剤を得るため、細胞賦活作用、コラーゲン産生促進作用、メラニン産生抑制作用、ヒアルロン酸産生促進作用及び抗酸化作用等のいずれかまたはこれらの作用のうち複数の作用を有する成分の検索と配合が試みられているが、安定性、副作用、効果などの点から未だ十分なものはない。 Skin aging symptoms such as wrinkles caused by external stress such as aging and ultraviolet rays, generation of spots, decreased skin elasticity, decreased function of skin dermal fibroblasts, degeneration and decrease of collagen, mucos including hyaluronic acid The decrease of polysaccharides, the formation and deposition of melanin by ultraviolet rays, and the oxidation of cells are important factors. However, as with conventional cosmetics, it is clear that skin aging symptoms cannot be sufficiently prevented simply by trying to retain moisture by combining biochemical products such as mucopolysaccharides and collagen and synthetic polymer products. It has become. Therefore, in order to obtain a skin external preparation having an anti-aging and improving action on the skin, any of cell activation, collagen production promoting action, melanin production inhibiting action, hyaluronic acid production promoting action and antioxidant action, etc. Of these, attempts have been made to search for and combine ingredients having a plurality of actions, but none are sufficient from the viewpoints of stability, side effects and effects.
また真皮組織に存在するコラーゲンとしては、I型とIII型が知られている。I型コラーゲンは弾力を保ち守る働きがあり、III型コラーゲンは、みずみずしさを保ち柔軟性をサポートする働きがあると言われている。III型とI型コラーゲンの割合は、乳児期には1対4であるのに対し、成人では1対10になるといわれており、III型コラーゲンは加齢に伴い急速に減少していく。皮膚の弾力性を維持、回復させるためには、I型コラーゲンのみではなく、III型コラーゲンが重要な役割を担っている。 As collagen existing in the dermis tissue, type I and type III are known. Type I collagen has a function of maintaining elasticity and protecting, and type III collagen is said to have a function of maintaining freshness and supporting flexibility. It is said that the ratio of type III and type I collagen is 1: 4 in infancy, but 1:10 in adults, and type III collagen decreases rapidly with age. In order to maintain and recover the elasticity of the skin, not only type I collagen but also type III collagen plays an important role.
加水分解性タンニンに関しては、収斂作用、抗酸化作用等が古くから知られている。加水分解性タンニンの1種であるオイゲニインに関しては、抗ウィルス作用(特許文献1参照)、DNA合成阻害作用(特許文献2参照)、IgE−IgRレセプター結合阻害作用(特許文献3参照)、グルコシダーゼ阻害作用(特許文献4参照)、フリーラジカル消去作用(特許文献5参照)等が知られている。しかしながら、加水分解性タンニンが、コラーゲンの産生を促進する事に関しては、これまで知られていなかった。 Concerning hydrolyzable tannins, astringent action, antioxidant action, etc. have been known for a long time. Regarding Eugenin, which is one of hydrolyzable tannins, antiviral action (see Patent Document 1), DNA synthesis inhibitory action (see Patent Document 2), IgE-IgR receptor binding inhibitory action (see Patent Document 3), glucosidase inhibition An action (see Patent Document 4), a free radical scavenging action (see Patent Document 5), and the like are known. However, it has not been known so far that hydrolyzable tannin promotes the production of collagen.
本発明は、真皮の構成成分である、コラーゲン、特にIII型コラーゲンの産生を促進するコラーゲン産生促進剤を提供することを目的とした。 An object of the present invention is to provide a collagen production promoter that promotes the production of collagen, particularly type III collagen, which is a constituent component of the dermis.
本発明は、加水分解性タンニンを有効成分とするコラーゲン産生促進剤、特にIII型コラーゲン産生促進剤である。 The present invention is a collagen production promoter, particularly a type III collagen production promoter comprising hydrolyzable tannin as an active ingredient.
本発明のコラーゲン産生促進剤、時にIII型コラーゲン産生促進剤の有効成分である、加水分解性タンニンとしては、化学式(1) The hydrolyzable tannin, which is an active ingredient of the collagen production promoter of the present invention, and sometimes the type III collagen production promoter, has the chemical formula (1)
(式1中、
R1は水酸基若しくは化学式(2)で示される残基、若しくはR2と共同して化学式(3)に示される残基であり、
R2は水酸基若しくは化学式(2)で示される残基、若しくはR1と共同して化学式(3)に示される残基であり、
R3は水酸基若しくは化学式(2)で示される残基であり、
R4は水酸基若しくは化学式(2)で示される残基であり、
R5は水酸基若しくは化学式(2)で示される残基であり、
R6は同一若しくは異なってもよく、水素基若しくは化学式(4)若しくは化学式(5)若しくは化学式(6)で示される基であり、
R1〜R5すべてが水酸基であることはない)
(In Formula 1,
R1 is a hydroxyl group or a residue represented by chemical formula (2), or a residue represented by chemical formula (3) in combination with R2,
R2 is a hydroxyl group or a residue represented by the chemical formula (2), or a residue represented by the chemical formula (3) together with R1,
R3 is a hydroxyl group or a residue represented by the chemical formula (2),
R4 is a hydroxyl group or a residue represented by the chemical formula (2),
R5 is a hydroxyl group or a residue represented by the chemical formula (2),
R6 may be the same or different and is a hydrogen group or a group represented by the chemical formula (4), the chemical formula (5) or the chemical formula (6);
R1 to R5 are not all hydroxyl groups)
で示される加水分解性タンニンを用いることができる。 The hydrolyzable tannin shown by can be used.
本発明において、加水分解性タンニンとしては、化学式(7)で示されるオイゲニインを用いることができる。 In the present invention, as the hydrolyzable tannin, eugeniin represented by the chemical formula (7) can be used.
本発明において、加水分解性タンニンとしては、化学式(8)で示される化合物を用いることができる。 In the present invention, as the hydrolyzable tannin, a compound represented by the chemical formula (8) can be used.
(式8中R7は同一若しくは異なってもよく、水素基もしくは化学式(4)若しくは化学式(5)若しくは化学式(6)であり、
R8は水素基もしくは化学式(9)若しくは化学式(10)で示される化合物である)
(R7 in formula 8 may be the same or different, and is a hydrogen group, chemical formula (4), chemical formula (5) or chemical formula (6),
R8 is a hydrogen group or a compound represented by chemical formula (9) or chemical formula (10))
本発明によれば、真皮線維芽細胞におけるコラーゲン特にIII型コラーゲン産生促進効果に優れたコラーゲン産生促進剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the collagen production promoter excellent in the collagen dermal fibroblast, especially the III type collagen production promotion effect can be provided.
本発明は、加水分解性タンニンを有効成分とする、コラーゲン産生促進剤、特にIII型コラーゲン産生促進剤に関する。 The present invention relates to a collagen production promoter, particularly a type III collagen production promoter, comprising hydrolyzable tannin as an active ingredient.
本発明で用いる加水分解性タンニンは、没食子酸やエラグ酸などの芳香族化合物とグルコースなどの糖がエステル結合を形成した構造を有する化合物であり、植物界に普遍的に存在する。本発明においては、かかる加水分解性タンニンの中でも、一般式(1) The hydrolyzable tannin used in the present invention is a compound having a structure in which an aromatic compound such as gallic acid or ellagic acid and a sugar such as glucose form an ester bond, and is universally present in the plant kingdom. In the present invention, among such hydrolyzable tannins, the general formula (1)
(式1中、
R1は水酸基若しくは化学式(2)で示される残基、若しくはR2と共同して化学式(3)に示される残基であり、
R2は水酸基若しくは化学式(2)で示される残基、若しくはR1と共同して化学式(3)に示される残基であり、
R3は水酸基若しくは化学式(2)で示される残基であり、
R4は水酸基若しくは化学式(2)で示される残基であり、
R5は水酸基若しくは化学式(2)で示される残基であり、
R6は同一若しくは異なってもよく、水素基若しくは化学式(4)若しくは化学式(5)若しくは化学式(6)で示される基であり、
R1〜R5すべてが水酸基であることはない)
で示される加水分解性タンニンを用いることができる。
(In Formula 1,
R1 is a hydroxyl group or a residue represented by chemical formula (2), or a residue represented by chemical formula (3) in combination with R2,
R2 is a hydroxyl group or a residue represented by the chemical formula (2), or a residue represented by the chemical formula (3) together with R1,
R3 is a hydroxyl group or a residue represented by the chemical formula (2),
R4 is a hydroxyl group or a residue represented by the chemical formula (2),
R5 is a hydroxyl group or a residue represented by the chemical formula (2),
R6 may be the same or different and is a hydrogen group or a group represented by the chemical formula (4), the chemical formula (5) or the chemical formula (6);
R1 to R5 are not all hydroxyl groups)
The hydrolyzable tannin shown by can be used.
本発明において、加水分解性タンニンとしては、化学式(7)で示されるオイゲニインを用いることもできる。 In the present invention, as the hydrolyzable tannin, eugeniin represented by the chemical formula (7) can also be used.
本発明において、加水分解性タンニンとしては、化学式(8)で示される化合物を用いることができる。 In the present invention, as the hydrolyzable tannin, a compound represented by the chemical formula (8) can be used.
(式8中R7は同一若しくは異なってもよく、水素基もしくは化学式(4)若しくは化学式(5)若しくは化学式(6)であり、
R8は水素基もしくは化学式(9)若しくは化学式(10)で示される化合物である)
(R7 in formula 8 may be the same or different, and is a hydrogen group, chemical formula (4), chemical formula (5) or chemical formula (6),
R8 is a hydrogen group or a compound represented by chemical formula (9) or chemical formula (10))
本発明の有効成分である、加水分解性タンニンは、市販の加水分解性タンニンを用いても、また植物から抽出したものを用いてもよい。 The hydrolyzable tannin which is an active ingredient of the present invention may be a commercially available hydrolyzable tannin or one extracted from a plant.
なお、オイゲニインは、丁子、チユ、ゲンノショウコ、バラなどに含まれる加水分解性タンニンである。本発明においては、これらの植物から公知の方法により分離したオイゲニインを用いることもできるが、これらのオイゲニインを含有する植物の抽出物を使用することもできる。また、市販されているオイゲニイン(例えば、長良サイエンス社製eigeniin)を用いることもできる。 Eugenin is a hydrolyzable tannin contained in clove, chiyu, genokosho, rose and the like. In the present invention, eugeniin separated from these plants by a known method can be used, but an extract of a plant containing these eugeniins can also be used. Also, commercially available eugenin (for example, eigenin manufactured by Nagara Science Co., Ltd.) can be used.
本発明者等は、今回ドゥアバンガ属植物の抽出物に、オイゲニインが高含有率で含まれていることを見いだした。ドゥアバンガ、丁子、バラのオイゲニインの含有量を表1に示す。 The present inventors have now found that Eugeniin is contained at a high content in the extract of the genus Duavanga. Table 1 shows the contents of duabanga, clove and rose eugenin.
表1の通り、ドゥアバンガの葉部には、これまでオイゲニインの含有が知られていたバラや丁子よりも高含有率で、オイゲニインを含有することが示された。 As shown in Table 1, it was shown that duabanga leaves contained eugeniin at a higher content than roses and cloves known to contain eugeniin.
オイゲニインは、例えば、ドゥアバンガ属植物抽出物に、液−液分配抽出、各種クロマトグラフィー、膜分離等、加水分解性タンニンを濃縮するのに有効な精製操作を施した後、オクタデシルシリル化シリカゲル(ODS)等を用いた液体クロマトグラフィー処理を行うことにより得ることができる。 Eugeniin, for example, is subjected to a purification operation effective for concentrating hydrolyzable tannin, such as liquid-liquid partition extraction, various chromatographies, membrane separation, and the like, after being subjected to octadecylsilylated silica gel (ODS). ) Etc. can be obtained by performing liquid chromatography.
オイゲニインは、具体的には、下記工程(a)〜(c)により得ることができる。
工程(a)
工程(a)は、ドゥアバンガ属植物を水、親水性有機溶媒又はこれらの混合溶媒で抽出する工程である。
Specifically, eugeniin can be obtained by the following steps (a) to (c).
Step (a)
Step (a) is a step of extracting Duabanga plants with water, a hydrophilic organic solvent, or a mixed solvent thereof.
抽出原料として用いるドゥアバンガ属植物の部位は特に限定されるものではなく、例えば、葉部、枝部、幹部等の地上部、果皮等の部位を抽出原料として用いることができるが、これらのうち、特に葉部等を抽出原料として用いることが好ましい。 The part of the plant belonging to the genus Duabanga used as the extraction raw material is not particularly limited, and for example, the above-mentioned parts such as leaves, branches, trunks, and the like can be used as the extraction raw material. In particular, it is preferable to use a leaf or the like as an extraction raw material.
抽出原料は、乾燥した後、そのまま又は粗砕機を用いて粉砕し、抽出溶媒による抽出に供する。この際、抽出原料の乾燥は天日で行ってもよいし、通常使用される乾燥機を用いて行ってもよい。 After the extraction raw material is dried, it is pulverized as it is or using a crusher, and is subjected to extraction with an extraction solvent. At this time, the extraction raw material may be dried in the sun or using a commonly used dryer.
抽出溶媒としては、極性溶媒を用いることが好ましく、水若しくは親水性有機溶媒又はこれらの混合液を、室温又は溶媒の沸点以下の温度で用いることが特に好ましい。 As the extraction solvent, it is preferable to use a polar solvent, and it is particularly preferable to use water, a hydrophilic organic solvent, or a mixture thereof at room temperature or a temperature not higher than the boiling point of the solvent.
抽出溶媒として用い得る水としては、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等の他、これらに各種処理を施したものが含まれる。水に施す処理としては、例えば、精製、加熱、殺菌、ろ過、イオン交換、浸透圧の調整、緩衝化等が含まれる。従って、本発明において抽出溶媒として用い得る水には、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等も含まれる。 Examples of water that can be used as the extraction solvent include pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, and the like, as well as water that has been subjected to various treatments. Examples of the treatment applied to water include purification, heating, sterilization, filtration, ion exchange, adjustment of osmotic pressure, buffering, and the like. Accordingly, water that can be used as the extraction solvent in the present invention includes purified water, hot water, ion-exchanged water, physiological saline, phosphate buffer, phosphate buffered saline, and the like.
抽出溶媒として用い得る親水性有機溶媒としては、例えば、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール等の炭素数1〜5の低級アルコール;アセトン、メチルエチルケトン等の低級脂肪族ケトン;1,3−ブチレングリコール、プロピレングリコール、グリセリン等の炭素数2〜5の多価アルコール等が挙げられる。 Examples of the hydrophilic organic solvent that can be used as the extraction solvent include lower alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propyl alcohol, and isopropyl alcohol; lower aliphatic ketones such as acetone and methyl ethyl ketone; 1,3-butylene glycol C2-5 polyhydric alcohols such as propylene glycol and glycerin.
2種以上の極性溶媒の混合液を抽出溶媒として用いる場合、その混合比は適宜調整することができる。例えば、水と低級脂肪族アルコールとの混合液を使用する場合には、水と低級脂肪族アルコールとの混合比を1:99〜99:1(容量比)とすることができる。 When using the liquid mixture of 2 or more types of polar solvents as an extraction solvent, the mixing ratio can be adjusted suitably. For example, when using the liquid mixture of water and a lower aliphatic alcohol, the mixing ratio of water and a lower aliphatic alcohol can be set to 1: 99-99: 1 (volume ratio).
ドゥアバンガ属植物からオイゲニインを抽出する際の抽出方法は特に限定されるものではなく、室温又は還流加熱下で、任意の装置を用いることができる。例えば、抽出溶媒を満たした処理槽に抽出原料を投入し、必要に応じて時々攪拌しながら、1〜48時間静置して可溶性成分を溶出した後、ろ過して固形物を除去し、得られた抽出液から抽出溶媒を留去し、乾燥することにより抽出物が得られる。抽出溶媒量は通常、抽出原料の1〜100倍量(重量比)であり、抽出温度は、通常20〜90℃である。 The extraction method when extracting Eugenin from a plant of the genus Duavanga is not particularly limited, and any apparatus can be used at room temperature or under reflux heating. For example, the extraction raw material is put into a treatment tank filled with an extraction solvent, and after standing for 1 to 48 hours with occasional stirring as necessary to elute soluble components, the solids are removed by filtration to obtain The extract is obtained by evaporating the extraction solvent from the extract and drying. The amount of extraction solvent is usually 1 to 100 times (weight ratio) of the extraction raw material, and the extraction temperature is usually 20 to 90 ° C.
工程(b)
工程(b)は、前記工程(a)で得られた抽出物を吸着剤に吸着させた後、水、水溶性溶媒又はこれらの混合溶媒で溶出する工程である。
工程(b)は、前記工程(a)で得られた抽出物の加水分解性タンニン含量を高めるとともに、脱色、脱臭、活性向上等を目的として精製する工程である。
Step (b)
Step (b) is a step in which the extract obtained in step (a) is adsorbed on an adsorbent and then eluted with water, a water-soluble solvent or a mixed solvent thereof.
The step (b) is a step of increasing the hydrolyzable tannin content of the extract obtained in the step (a) and purifying it for the purpose of decolorization, deodorization, activity improvement and the like.
抽出物に含まれる親水性有機溶媒は、吸着剤に吸着させる前に、必要に応じて留去する。親水性有機溶媒を留去した抽出物は、例えば、水、水溶性溶媒又はこれらの混合溶媒に溶解又は懸濁させた後、吸着剤に吸着させる。 The hydrophilic organic solvent contained in the extract is distilled off as necessary before adsorbing to the adsorbent. The extract obtained by distilling off the hydrophilic organic solvent is dissolved or suspended in, for example, water, a water-soluble solvent or a mixed solvent thereof, and then adsorbed on an adsorbent.
溶解、懸濁又は溶出に用いられる水溶性溶媒としては、上記した親水性有機溶媒を用いることができるが、上記した炭素数1〜5の低級アルコール、この中でも特に、メタノール、エタノール等を用いることが好ましい。水及び水溶性溶媒の混合溶媒を用いる場合、その混合比は適宜調整することができる。例えば、水とエタノールとの混合溶媒を使用する場合、水とエタノールとの混合比を90:10〜1:99(容量比)、好ましく80:20〜20:80(容量比)とすることができる。 As the water-soluble solvent used for dissolution, suspension or elution, the above-mentioned hydrophilic organic solvents can be used, and the above-mentioned lower alcohols having 1 to 5 carbon atoms, particularly methanol, ethanol, etc. are used. Is preferred. When a mixed solvent of water and a water-soluble solvent is used, the mixing ratio can be adjusted as appropriate. For example, when a mixed solvent of water and ethanol is used, the mixing ratio of water and ethanol is 90:10 to 1:99 (volume ratio), preferably 80:20 to 20:80 (volume ratio). it can.
吸着剤は、特に限定されるものではないが、イオン交換樹脂、合成吸着樹脂、活性炭、キレート樹脂、シリカゲル、アルミナゲル系吸着剤、多孔質ガラス等の公知の吸着剤を単独で又は組み合わせて用いることができる。好ましくは、多孔性合成吸着樹脂であるダイヤイオンHP−20、セパビーズSP−207(いずれも三菱化学(株)製)等の多孔性合成吸着剤を用いたカラムクロマトグラフィーと、オクタデシルシリル化シリカゲル(ODS)であるクロマトレックスODS、DM1020T(富士シリシア化学(株)製)等を充填剤として用いた逆相カラムクロマトグラフィーとを併用する。 The adsorbent is not particularly limited, but known adsorbents such as ion exchange resin, synthetic adsorption resin, activated carbon, chelate resin, silica gel, alumina gel type adsorbent, and porous glass are used alone or in combination. be able to. Preferably, column chromatography using a porous synthetic adsorbent such as Diaion HP-20 and Sepabead SP-207 (both manufactured by Mitsubishi Chemical Corporation), which are porous synthetic adsorption resins, and octadecylsilylated silica gel ( ODS) and chromatolex ODS, DM1020T (manufactured by Fuji Silysia Chemical Co., Ltd.) and the like are used in combination with reverse phase column chromatography using a filler.
工程(c)
工程(c)は、前記工程(b)で得られた溶出液を、移動相として水、水溶性溶媒又はこれらの混合溶媒を用いた液体クロマトグラフィーにより分画する工程である。
Step (c)
Step (c) is a step of fractionating the eluate obtained in step (b) by liquid chromatography using water, a water-soluble solvent or a mixed solvent thereof as a mobile phase.
液体クロマトグラフィーによる分画方法は特に制限されるものではなく、通常の方法で行うことができる。例えば、固定相としては、シリカゲル、ODS、イオン交換樹脂等の公知の担体を単独で又は組み合わせて用いることができる。 The fractionation method by liquid chromatography is not particularly limited, and can be performed by a usual method. For example, as the stationary phase, known carriers such as silica gel, ODS, and ion exchange resin can be used alone or in combination.
水溶性溶媒としては、上記した親水性有機溶媒を用いることができるが、上記した炭素数1〜5の低級アルコール、この中でも特にメタノール、エタノール、アセトニトリル等を用いることが好ましい。水及び水溶性溶媒の混合溶媒を用いる場合、その混合比は適宜調整することができる。例えば、水とメタノールとの混合溶媒を使用する場合、水とエタノールとの混合比を2:8〜6:4(容量比)、好ましく3:7(容量比)とすることができる。 As the water-soluble solvent, the above-described hydrophilic organic solvent can be used, and it is preferable to use the above-described lower alcohol having 1 to 5 carbon atoms, particularly methanol, ethanol, acetonitrile and the like. When a mixed solvent of water and a water-soluble solvent is used, the mixing ratio can be adjusted as appropriate. For example, when a mixed solvent of water and methanol is used, the mixing ratio of water and ethanol can be set to 2: 8 to 6: 4 (volume ratio), preferably 3: 7 (volume ratio).
液体クロマトグラフィーを利用してオイゲニインを含有する画分を分画することにより、精製されたオイゲニインを得ることができる。 By fractionating a fraction containing eugenin using liquid chromatography, purified eugeniin can be obtained.
本発明のコラーゲン産生促進剤は、皮膚に外用するだけではなく、経口摂取も可能であり、食品、飲料、あるいは医薬品などにも応用することが可能である。 The collagen production promoter of the present invention is not only externally applied to the skin, but can also be taken orally, and can be applied to foods, beverages, pharmaceuticals, and the like.
また、本発明のコラーゲン産生促進剤を皮膚外用剤に配合することにより、肌のシワ、タルミ、ハリ等の皮膚老化症状の防止・改善に優れた効果を発揮する皮膚外用剤を得ることができる。さらに、発明のコラーゲン産生促進剤は、美容、健康維持、又は栄養補給を目的とするような食品や飲料にも用いることもできる。 In addition, by incorporating the collagen production promoter of the present invention into a skin external preparation, a skin external preparation that exhibits an excellent effect in preventing and improving skin aging symptoms such as skin wrinkles, tarmi, and firmness can be obtained. . Furthermore, the collagen production promoter of the invention can also be used in foods and beverages for the purpose of beauty, health maintenance or nutritional supplementation.
本発明のコラーゲン産生促進剤を皮膚外用剤に配合する際の配合量は、皮膚外用剤の種類や使用目的等によって調整することができるが、効果や安定性などの点から、全量に対して0.0001〜50.0質量%が好ましく、より好ましくは、0.001〜25.0質量%である。 The blending amount when blending the collagen production promoter of the present invention into the external preparation for skin can be adjusted according to the type and intended use of the external preparation for skin, but from the viewpoint of effect and stability, the total amount 0.0001-50.0 mass% is preferable, More preferably, it is 0.001-25.0 mass%.
本発明のコラーゲン産生促進剤を配合する皮膚外用剤の剤型は任意であり、例えば、ローションなどの可溶化系、クリームや乳液などの乳化系、カラミンローション等の分散系として提供することができる。さらに、噴射剤と共に充填したエアゾール、軟膏剤、粉末、顆粒などの種々の剤型で提供することもできる。 The dosage form of the external preparation for skin containing the collagen production promoter of the present invention is arbitrary, and can be provided, for example, as a solubilizing system such as lotion, an emulsifying system such as cream or emulsion, or a dispersing system such as calamine lotion. . Furthermore, it can also be provided in various dosage forms such as aerosols, ointments, powders and granules filled with a propellant.
以下に本発明の詳細を実施例を用いて説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。 The details of the present invention will be described below with reference to examples, but the technical scope of the present invention is not limited thereto.
[製造例1] 加水分解性タンニン含有植物抽出物の調製
ドゥアバンガ属植物(Duabanga grandiflora)の葉乾燥粉砕物100gを、1Lの50容量%エタノール水溶液に分散させ、撹拌しながら70℃にて2時間抽出した。抽出上清を濾別した。ろ液を減圧濃縮後、凍結乾燥を行い、ドゥアバンガ抽出物19.1gを得た。
[Production Example 1] Preparation of hydrolyzable tannin-containing plant extract 100 g of dried dry ground powder of Duabanga grandiflora was dispersed in 1 L of 50 vol% ethanol aqueous solution and stirred at 70 ° C for 2 hours. Extracted. The extraction supernatant was filtered off. The filtrate was concentrated under reduced pressure and lyophilized to obtain 19.1 g of Duabanga extract.
[製造例2] 加水分解性タンニン含有植物抽出物分画物の調製
得られたドゥアバンガ抽出物17.19gに水50mLを加え懸濁させ、オープンカラムに充填した多孔性樹脂(ダイヤイオンHP−20:三菱化学社製)上に付し、水:エタノール溶媒を100:0、80:20、60:40、40:60、20:80、0.5:99.5の順で順次溶出させ、溶出物を濃縮乾固して、各溶出画分0、2、4、6、8、10を得た。
[Production Example 2] Preparation of hydrolyzable tannin-containing plant extract fraction A porous resin (Diaion HP-20) filled with an open column was prepared by adding 50 mL of water to 17.19 g of the resulting Duabanga extract and suspending it. : Made by Mitsubishi Chemical Co., Ltd.), and water: ethanol solvent is sequentially eluted in the order of 100: 0, 80:20, 60:40, 40:60, 20:80, 0.5: 99.5, The eluate was concentrated to dryness to obtain elution fractions 0, 2, 4, 6, 8, and 10.
[製造例3]
溶出画分4を40容量%メタノール水溶液に溶解し、LC−MSにて、紫外部吸収画分を分取し、濃縮乾固する事により、ドゥアバンガA相(分子量:938)並びにドゥアバンガB相(分子量:1106)を単離した。それぞれ収率は、4.06%、8.51%であった。
[液体クロマトグラフィー条件]
固定相:Inertsil ODS-3(GLサイエンス社製)
カラム径:4.6mm
カラム長:150mm
移動相:30容量%メタノール水溶液
移動相流量:1mL/min
検出:UV
[Production Example 3]
Dissolve the eluted fraction 4 in a 40% by volume methanol aqueous solution, collect the ultraviolet absorption fraction with LC-MS, concentrate and dry to obtain the Duabanga A phase (molecular weight: 938) and Duabanga B phase ( Molecular weight: 1106) was isolated. The yields were 4.06% and 8.51%, respectively.
[Liquid chromatography conditions]
Stationary phase: Inertsil ODS-3 (GL Sciences)
Column diameter: 4.6 mm
Column length: 150mm
Mobile phase: 30% by volume methanol aqueous solution Mobile phase flow rate: 1 mL / min
Detection: UV
単離したオイゲニイン並びに化学式(7)で示される化合物について、1H−NMR及び13C−NMR分析を行った。結果を図1〜図4に示す。分子量並びに1H−NMR及び13C−NMR分析の結果、ドゥアバンガA相は、化学式(6)で示されるオイゲニインであることが確認された。 1 H-NMR and 13 C-NMR analyzes were performed on the isolated eugenin and the compound represented by the chemical formula (7). The results are shown in FIGS. As a result of molecular weight and 1 H-NMR and 13 C-NMR analyses, it was confirmed that the Duavanga A phase was eugeniin represented by the chemical formula (6).
[III型コラーゲン産生促進作用]
正常ヒト真皮繊維芽細胞を1ウェル当り2.0×104個となるように96ウェルマイクロプレートに播種した。播種培地にはダルベッコ改変イーグル培地(DMEM)に5質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、0.5質量%FBS添加DMEM培地にて各濃度に調整したサンプル培養液に交換しさらに24時間培養した。
培養上清中に分泌されたタイプIIIコラーゲン量はELISA法を用い、最後は標識されたペルオキシダーゼに対し2,2’−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)及び過酸化水素を添加し反応させた後、マイクロプレートリーダーにて405nmの吸光度を測定した。評価ではサンプル培養液の他にネガティブコントロールとして0.5質量%FBS添加DMEM培地を用いた。PIERCE社製BCA PROTEIN ASSAY Kitにてタンパク量を測定し単位タンパク量当りのコラーゲン産生量を求めた。
評価はネガティブコントロールの単位当りコラーゲン産生量を100とした時の相対値を求めて行った。また、コントロールとの有意差検定(t検定)を行い、表中の*及び**にて示した。有意確率5%未満(P<0.05)を*で、有意確率1%未満(P<0.01)を**でそれぞれ表した。
[Promoting action of type III collagen production]
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) to which 5% by mass of fetal bovine serum (FBS) was added was used. After 24 hours, the culture medium was replaced with a sample culture solution adjusted to each concentration in a DMEM medium supplemented with 0.5 mass% FBS, and further cultured for 24 hours.
The amount of type III collagen secreted into the culture supernatant was determined by ELISA, and finally 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) against labeled peroxidase. And after adding hydrogen peroxide and making it react, the light absorbency of 405 nm was measured with the microplate reader. In the evaluation, 0.5% by mass FBS-added DMEM medium was used as a negative control in addition to the sample culture solution. The amount of protein was measured with BCA PROTEIN ASSAY Kit manufactured by PIERCE, and the amount of collagen produced per unit protein was determined.
The evaluation was performed by obtaining a relative value when the collagen production amount per unit of the negative control was 100. Moreover, the significant difference test (t test) with control was performed, and it showed with * and ** in the table | surface. A significance probability of less than 5% (P <0.05) was represented by *, and a significance probability of less than 1% (P <0.01) was represented by **.
評価結果を、試料無添加のコントロールにおけるIII型コラーゲン産生作用を100とした相対値にて表2〜表10に示す。また、コントロールとの有意差検定(t検定)を行い、表中の*及び**にて示した。有意確率5%未満(P<0.05)を*で、有意確率1%未満(P<0.01)を**でそれぞれ表した。 The evaluation results are shown in Tables 2 to 10 as relative values with the type III collagen production action in the control with no sample added as 100. Moreover, the significant difference test (t test) with control was performed, and it showed with * and ** in the table | surface. A significance probability of less than 5% (P <0.05) was represented by *, and a significance probability of less than 1% (P <0.01) was represented by **.
表3〜表10より明らかなように、本発明の加水分解性タンニンを含有する植物抽出物、並びに加水分解性タンニンは、高いIII型コラーゲン産生促進効果を発揮していた。 As apparent from Tables 3 to 10, the plant extract containing the hydrolyzable tannin of the present invention and the hydrolyzable tannin exhibited a high type III collagen production promoting effect.
Claims (5)
R1は水酸基若しくは化学式(2)で示される残基、若しくはR2と共同して化学式(3)に示される残基であり、
R2は水酸基若しくは化学式(2)で示される残基、若しくはR1と共同して化学式(3)に示される残基であり、
R3は水酸基若しくは化学式(2)で示される残基であり、
R4は水酸基若しくは化学式(2)で示される残基であり、
R5は水酸基若しくは化学式(2)で示される残基であり、
R6は同一若しくは異なってもよく、水素基若しくは化学式(4)若しくは化学式(5)若しくは化学式(6)で示される基であり、
R1〜R5すべてが水酸基であることはない)
で示される加水分解性タンニンを有効成分とする請求項1若しくは請求項2に記載のコラーゲン産生促進剤。
R1 is a hydroxyl group or a residue represented by chemical formula (2), or a residue represented by chemical formula (3) in combination with R2,
R2 is a hydroxyl group or a residue represented by the chemical formula (2), or a residue represented by the chemical formula (3) together with R1,
R3 is a hydroxyl group or a residue represented by the chemical formula (2),
R4 is a hydroxyl group or a residue represented by the chemical formula (2),
R5 is a hydroxyl group or a residue represented by the chemical formula (2),
R6 may be the same or different and is a hydrogen group or a group represented by the chemical formula (4), the chemical formula (5) or the chemical formula (6);
R1 to R5 are not all hydroxyl groups)
The collagen production promoter of Claim 1 or Claim 2 which uses the hydrolyzable tannin shown by this as an active ingredient.
R8は水素基もしくは化学式(9)若しくは化学式(10)
R8 represents a hydrogen group, chemical formula (9), or chemical formula (10).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006254393A JP2008074747A (en) | 2006-09-20 | 2006-09-20 | Collagen production promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006254393A JP2008074747A (en) | 2006-09-20 | 2006-09-20 | Collagen production promoter |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2008074747A true JP2008074747A (en) | 2008-04-03 |
Family
ID=39347176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006254393A Pending JP2008074747A (en) | 2006-09-20 | 2006-09-20 | Collagen production promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2008074747A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014042261A1 (en) * | 2012-09-13 | 2014-03-20 | 森下仁丹株式会社 | Sirtuin gene potentiator, and pharmaceutical product, cosmetic product, and food product using same |
CN104359569A (en) * | 2014-10-31 | 2015-02-18 | 成都利邦科技有限公司 | Temperature detecting circuit of combination lock |
JP2015033360A (en) * | 2013-08-09 | 2015-02-19 | 株式会社シェフコ | Hydrogen-containing beverage containing functional raw material |
JP2015215172A (en) * | 2014-05-07 | 2015-12-03 | ポーラ化成工業株式会社 | Screening method of skin improving agent |
-
2006
- 2006-09-20 JP JP2006254393A patent/JP2008074747A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014042261A1 (en) * | 2012-09-13 | 2014-03-20 | 森下仁丹株式会社 | Sirtuin gene potentiator, and pharmaceutical product, cosmetic product, and food product using same |
CN104703615A (en) * | 2012-09-13 | 2015-06-10 | 森下仁丹株式会社 | Sirtuin gene potentiator, and pharmaceutical product, cosmetic product, and food product using same |
JPWO2014042261A1 (en) * | 2012-09-13 | 2016-08-18 | 森下仁丹株式会社 | Sirtuin gene activity enhancer and pharmaceuticals, cosmetics and foods using the same |
JP2015033360A (en) * | 2013-08-09 | 2015-02-19 | 株式会社シェフコ | Hydrogen-containing beverage containing functional raw material |
JP2015215172A (en) * | 2014-05-07 | 2015-12-03 | ポーラ化成工業株式会社 | Screening method of skin improving agent |
CN104359569A (en) * | 2014-10-31 | 2015-02-18 | 成都利邦科技有限公司 | Temperature detecting circuit of combination lock |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4941991B2 (en) | Proanthocyanidin oligomer production method | |
JP5599090B2 (en) | Type I collagen production promoter | |
JP5615966B2 (en) | Piceatannol-containing composition | |
JP5415037B2 (en) | Collagen production promoter | |
JP2010030911A (en) | Collagen production promotor | |
JP5751981B2 (en) | Novel phenylethanoid glycosides and skin cosmetics | |
JP2008074747A (en) | Collagen production promoter | |
JP4813917B2 (en) | Skin cosmetics | |
WO2022215441A1 (en) | Novel polyphenol compound | |
JP4822718B2 (en) | Novel C-glycoside compounds, collagen production promoters, skin cosmetics and cosmetic foods and drinks | |
KR100363112B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
JP6923100B1 (en) | New isoflavone compound | |
JP5360957B2 (en) | Cholesterol synthesis promoter and hyaluronic acid production promoter | |
JP6688585B2 (en) | Barrier function improver | |
JP2007008847A (en) | Cosmetics | |
JP2006008571A (en) | Moisturizer, antioxidant, antiaging agent, skin cosmetic and beauty drink and food | |
JP5052026B2 (en) | Novel compounds and their production methods and uses | |
JP5991877B2 (en) | Cosmetics containing young leaf extract | |
KR100363111B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
JP5992661B2 (en) | Hyaluronic acid production promoter | |
JP4431301B2 (en) | Cancer cell apoptosis inducer, method for producing the same, anticancer agent containing the same as an active ingredient, food preparation and cosmetics | |
JP7570615B2 (en) | Antioxidant, method for producing antioxidant, and method for inhibiting the progress of oxidation reaction | |
JP2013249265A (en) | Whitening agent and skin cosmetic | |
JP2007230917A (en) | Collagen production promoter | |
JP4728612B2 (en) | Immunostimulants, antitumor agents, anti-aging agents, anti-obesity agents and skin cosmetics |